West Pharmaceutical Services, Inc.WSTNYSE
Loading
R&D Expenses Over TimeStrong
Percentile Rank100
3Y CAGR+8.3%
5Y CAGR+9.6%
Year-over-Year Change
Research and development spending
3Y CAGR
+8.3%/yr
vs +9.8%/yr prior
5Y CAGR
+9.6%/yr
Consistent
Acceleration
-1.5pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.6x
Solid growth
Streak
6 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $74.30M | +7.5% |
| 2024 | $69.10M | +1.0% |
| 2023 | $68.40M | +16.9% |
| 2022 | $58.50M | +10.8% |
| 2021 | $52.80M | +12.6% |
| 2020 | $46.90M | +20.6% |
| 2019 | $38.90M | -3.5% |
| 2018 | $40.30M | +3.1% |
| 2017 | $39.10M | +6.3% |
| 2016 | $36.80M | - |